{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:30:18Z","timestamp":1793377818648,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2500404"],"award-info":[{"award-number":["2021YFC2500404"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Cancer Center"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jncc.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:06:43Z","timestamp":1772867203000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A global review and perspective on prostate cancer survival: findings from survival studies of cancer registration data"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9688-7843","authenticated-orcid":false,"given":"Yuxin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3840-9915","authenticated-orcid":false,"given":"Yongbing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.jncc.2026.01.005_bib0002","article-title":"Burden of prostate cancer in China, 1990-2019: findings from the 2019 global burden of disease study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0003","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"11","key":"10.1016\/j.jncc.2026.01.005_bib0004","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study","volume":"20","author":"Arnold","year":"2019","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.mcna.2020.08.007","article-title":"Screening for prostate cancer","volume":"104","author":"Carlsson","year":"2020","journal-title":"Med Clin North Am"},{"issue":"41","key":"10.1016\/j.jncc.2026.01.005_bib0006","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001-2017","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0007","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.jncc.2026.01.005_bib0008","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","article-title":"Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness","volume":"45","author":"Larsen","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0009","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ejca.2008.11.032","article-title":"Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness","volume":"45","author":"Bray","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jncc.2026.01.005_bib0010","series-title":"Guidelines for Cancer Registration in China","first-page":"558","year":"2016"},{"issue":"14","key":"10.1016\/j.jncc.2026.01.005_bib0011","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.ejca.2011.03.011","article-title":"Choosing the relative survival method for cancer survival estimation","volume":"47","author":"Hakulinen","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jncc.2026.01.005_bib0012","first-page":"101","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"EDERER","year":"1961","journal-title":"Natl Cancer Inst Monogr"},{"issue":"9972","key":"10.1016\/j.jncc.2026.01.005_bib0013","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25 676 887 patients from 279 population based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"issue":"15","key":"10.1016\/j.jncc.2026.01.005_bib0015","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0016","first-page":"457","article-title":"Survival trend of prostate cancer in Qidong County, Jiangsu Province from 1987 to 2016","volume":"31","author":"YAN","year":"2022","journal-title":"China Cancer"},{"key":"10.1016\/j.jncc.2026.01.005_bib0017","series-title":"Incidence and Death Surveillance of Cancer in Wuxi Urban Area in 2010-2014 Years and Survival Analysis","author":"Yang","year":"2017"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0018","first-page":"241","article-title":"Survival rate of patients newly diagnosed with malignant cancers in Jiangyin City from 2012 to 2013","volume":"29","author":"LI","year":"2020","journal-title":"China Cancer"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0019","first-page":"509","article-title":"Survival analysis of malignant tumor patients in Minhang District, Shanghai from 2002 to 2005","volume":"22","author":"He","year":"2014","journal-title":"Chin J Prev Contr Chron Dis"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0020","first-page":"21","article-title":"Incidence and survival analysis of prostate cancer patients among permanent residents in Yangpu District of Shanghai during 2002\u20132012","volume":"35","author":"Han","year":"2014","journal-title":"AJSMMU"},{"key":"10.1016\/j.jncc.2026.01.005_bib0021","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2458-14-356","article-title":"Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai City Districts: a retrospective population-based cohort study, 2000-2009","volume":"14","author":"Hu","year":"2014","journal-title":"BMC Public Health"},{"issue":"06","key":"10.1016\/j.jncc.2026.01.005_bib0022","first-page":"321","article-title":"The analysis of the relative survival for urological cancer in urban Shanghai","volume":"32","author":"Shao","year":"2005","journal-title":"Chin J Clin Oncol"},{"issue":"08","key":"10.1016\/j.jncc.2026.01.005_bib0023","first-page":"806","article-title":"Incidence and survival trend of malignant tumors in Shenyang urban area from 2011 to 2018","volume":"49","author":"Lv","year":"2022","journal-title":"Cancer Res Prev Treat"},{"issue":"9","key":"10.1016\/j.jncc.2026.01.005_bib0024","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/jjco\/hyl068","article-title":"Res Grp population-based Canc R. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan","volume":"36","author":"Tsukuma","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jncc.2026.01.005_bib0025","first-page":"2151","article-title":"Cancer prevalence in Aichi, Japan for 2012: estimates based on incidence and survival data from population-based Cancer registry","volume":"18","author":"Nakagawa-Senda","year":"2017","journal-title":"APJCP"},{"key":"10.1016\/j.jncc.2026.01.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102269","article-title":"Difference in net survival using regional and national life tables in Japan","volume":"81","author":"Tanaka","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"162","key":"10.1016\/j.jncc.2026.01.005_bib0027","first-page":"171","article-title":"Cancer survival in Seoul, Republic of Korea, 1993-1997","author":"Ahn","year":"2011","journal-title":"IARC Sci Publ"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0028","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12885-021-09078-8","article-title":"Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018)","volume":"21","author":"Rasouli","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0029","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1470-2045(22)00704-5","article-title":"Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries","volume":"24","author":"Soerjomataram","year":"2023","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.jncc.2026.01.005_bib0030","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1001\/jama.283.22.2975","article-title":"Are increasing 5-year survival rates evidence of success against cancer?","volume":"283","author":"Welch","year":"2000","journal-title":"JAMA"},{"issue":"7\u20138","key":"10.1016\/j.jncc.2026.01.005_bib0031","first-page":"318","article-title":"Five-year cancer survival rates in Oklahoma from 1997 to 2008","volume":"109","author":"Campbell","year":"2016","journal-title":"J Okla State Med Assoc"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0032","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00008469-200410000-00004","article-title":"Incidence, mortality and survival from prostate cancer in Cuba, 1977-1999","volume":"13","author":"Alvarez","year":"2004","journal-title":"EurJ Cancer Prev"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.25100\/cm.v49i1.3629","article-title":"Health inequities and cancer survival in Manizales, Colombia: a population-based study","volume":"49","author":"Arias-Ortiz","year":"2018","journal-title":"Colomb Med"},{"key":"10.1016\/j.jncc.2026.01.005_bib0034","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3332\/ecancer.2018.799","article-title":"The mortality incidence ratio as an indicator of five-year cancer survival in metropolitan Lima","volume":"12","author":"Stenning-Persivale","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jncc.2026.01.005_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canep.2019.02.007","article-title":"Long-term survival of patients with prostate cancer in Martinique: results of a population-based study","volume":"59","author":"Joachim","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"10.1016\/j.jncc.2026.01.005_bib0036","first-page":"1265","article-title":"Prostate cancer clinical presentation, incidence, mortality and survival in Guadeloupe over the period 2008\u20132013 from a population-based cancer registry","volume":"28","author":"Deloumeaux","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0037","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12558-010-0075-3","article-title":"Cancer registry of Setif (Algeria): cancer incidence, trend and survival, 1986-2005","volume":"2","author":"Hamdi Cherif","year":"2010","journal-title":"J Afr Cancer"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0038","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ijc.34969","article-title":"Stage at diagnosis and survival among adult patients with cancer in Rwanda: a population-based study","volume":"155","author":"Hagenimana","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jncc.2026.01.005_bib0039","series-title":"Cancer Survival in Kampala, Uganda, 1993-1997","first-page":"243","author":"Wabinga","year":"2011"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0040","doi-asserted-by":"crossref","first-page":"e947","DOI":"10.1016\/S2214-109X(24)00130-X","article-title":"Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study","volume":"12","author":"Joko-Fru","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.jncc.2026.01.005_bib0041","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.annepidem.2015.03.012","article-title":"Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry","volume":"25","author":"El Mistiri","year":"2015","journal-title":"Ann Epidemiol"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0042","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ijc.20471","article-title":"Cancer survival in a southern African urban population","volume":"112","author":"Gondos","year":"2004","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.jncc.2026.01.005_bib0043","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2407-10-52","article-title":"German cancer statistics 2004","volume":"22","author":"Haberland","year":"2010","journal-title":"BMC Cancer"},{"issue":"1\u20132","key":"10.1016\/j.jncc.2026.01.005_bib0044","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000371717","article-title":"Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 years","volume":"38","author":"Doerr","year":"2015","journal-title":"Oncol Res Treat"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1008209005622","article-title":"Incidence, mortality and survival from prostate cancer in Vaud and Neuchatel, Switzerland, 1974-1994","volume":"9","author":"Levi","year":"1998","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.jncc.2026.01.005_bib0046","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1023\/A:1008339623847","article-title":"Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993","volume":"11","author":"Levi","year":"2000","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0047","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000020313","article-title":"Incidence, mortality and long-term survival from prostate cancer in Umbria, Italy, 1978-1994","volume":"38","author":"La Rosa","year":"2000","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0048","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.urology.2003.07.007","article-title":"Epidemiology of prostate cancer in the Umbria region of Italy: evidence of opportunistic screening effects","volume":"62","author":"La Rosa","year":"2003","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0049","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1186\/s12889-023-17440-7","article-title":"Significantly reduced incidence and improved survival from prostate cancer over 25 years","volume":"23","author":"Serda-Ferrer","year":"2023","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.jncc.2026.01.005_bib0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.34622","article-title":"Incidence, prevalence, and survival of prostate cancer in the UK","volume":"7","author":"Tan","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0051","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2006.07.021","article-title":"Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)","volume":"43","author":"Bossard","year":"2007","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0052","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/02841860802199808","article-title":"Cancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry","volume":"48","author":"Nennecke","year":"2009","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.jncc.2026.01.005_bib0053","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12094-017-1710-6","article-title":"Cancer survival in adult patients in Spain. Results from nine population-based cancer registries","volume":"20","author":"Chirlaque","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"10.1016\/j.jncc.2026.01.005_bib0054","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3390\/cancers14102441","article-title":"Cancer survival in adults in Spain: a population-based study of the Spanish network of Cancer registries (REDECAN)","volume":"14","author":"Guevara","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0055","first-page":"806","article-title":"Cancer survival during 2012-2018 in cancer registries of Shandong Province","volume":"56","author":"Jiang","year":"2022","journal-title":"Chin J Prev Med"},{"issue":"01","key":"10.1016\/j.jncc.2026.01.005_bib0056","first-page":"14","article-title":"Cancer survival in Haining and Jiashan cancer registry areas of Zhejiang Province","volume":"29","author":"LI","year":"2020","journal-title":"China Cancer"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0057","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/jjco\/hyq167","article-title":"Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study","volume":"41","author":"Matsuda","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jncc.2026.01.005_bib0058","doi-asserted-by":"crossref","first-page":"SUPPLS5","DOI":"10.3346\/jkms.2007.22.S.S5","article-title":"Cancer survival in Korea 1993-2002: a population-based study","volume":"22","author":"Jung","year":"2007","journal-title":"J Korean Med Sci"},{"issue":"8","key":"10.1016\/j.jncc.2026.01.005_bib0059","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3346\/jkms.2010.25.8.1113","article-title":"Cancer statistics in Korea: incidence, mortality and survival in 2006-2007","volume":"25","author":"Jung","year":"2010","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4143\/crt.2013.45.3.162","article-title":"Survival of Korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study","volume":"45","author":"Jung","year":"2013","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0061","first-page":"54","article-title":"Cancer survival analysis on population-based cancer registry data in Zhejiang province, China (2018-2019)","volume":"4","author":"Li","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"2","key":"10.1016\/j.jncc.2026.01.005_bib0062","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4143\/crt.2020.206","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017","volume":"52","author":"Hong","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.jncc.2026.01.005_bib0063","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/cncr.27968","article-title":"Assessing the utility of cancer registry processed cause of death in calculating cancer-specific survival","volume":"119","author":"Hu","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0064","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0065","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0066","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0067","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA A Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0068","doi-asserted-by":"crossref","first-page":"110","DOI":"10.25100\/cm.v45i3.1525","article-title":"Cancer survival in Cali, Colombia: a population-based study, 1995-2004","volume":"45","author":"Eduardo Bravo","year":"2014","journal-title":"Colomb Medica"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0069","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1743-7563.2011.01502.x","article-title":"Australian Institute of Health and WelfareCancer in Australia: actual incidence and mortality data from 1982 to 2007 and projections to 2010","volume":"7","year":"2011","journal-title":"Asia-Pac J Clin Onco"},{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150734","article-title":"Increasing disadvantages in cancer survival in New Zealand compared to Australia, between 2000-05 and 2006-10","volume":"11","author":"Elwood","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jncc.2026.01.005_bib0071","doi-asserted-by":"crossref","first-page":"586","DOI":"10.5694\/mja13.11134","article-title":"Geographic variation in prostate cancer survival in New South Wales","volume":"200","author":"Yu","year":"2014","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0072","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ijc.21909","article-title":"Trends in survival and excess risk of death after diagnosis of cancer in 1980-1996 in New South Wales, Australia","volume":"119","author":"Yu","year":"2006","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0073","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/annonc\/mdi186","article-title":"Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium","volume":"16","author":"Brenner","year":"2005","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.jncc.2026.01.005_bib0074","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036176","article-title":"Trends in cancer incidence and survival in the Augsburg study region results from the Augsburg cancer registry","volume":"10","author":"Grundmann","year":"2020","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5603\/NJO.2017.0057","article-title":"Changes in five-year relative survival rates in Poland in patients diagnosed in the years 1999-2010","volume":"67","author":"Wojciechowska","year":"2017","journal-title":"Nowotwory"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0076","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/21681805.2017.1392600","article-title":"Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014","volume":"51","author":"Innos","year":"2017","journal-title":"Scand J Urol"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0077","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canep.2013.11.002","article-title":"Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008","volume":"38","author":"Pavl\u00edk","year":"2014","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"10.1016\/j.jncc.2026.01.005_bib0078","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00008469-200304000-00008","article-title":"Prostate cancer in Italy before and during the \u201cPSA era\u201d: survival trend and prognostic determinants","volume":"12","author":"Quaglia","year":"2003","journal-title":"Eur J Cancer Prev"},{"issue":"15","key":"10.1016\/j.jncc.2026.01.005_bib0079","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ejca.2005.03.037","article-title":"Stage-specific survival of epithelial cancers in North-Holland\/Flevoland, The Netherlands","volume":"41","author":"Visser","year":"2005","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s12094-012-0824-0","article-title":"Trends in prostate cancer survival in Spain: results from population-based cancer registries","volume":"14","author":"Marcos-Gragera","year":"2012","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0081","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1470-2045(09)70028-2","article-title":"Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England","volume":"10","author":"Rachet","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jncc.2026.01.005_bib0082","first-page":"1001","article-title":"Prostate cancer survival in subSaharan Africa by age, stage at diagnosis, and human development index: a population-based registry study","volume":"32","author":"Seraphin","year":"2021","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0083","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4149\/neo_2021_210203N168","article-title":"Survival of cancer patients in Fujian, Southeast China: a population-based cancer registry study","volume":"68","author":"Zhou","year":"2021","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.jncc.2026.01.005_bib0084","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/iju.iju_38_23","article-title":"Overall survival of prostate cancer from Sangrur and Mansa cancer registries of Punjab state, India","volume":"39","author":"Budukh","year":"2023","journal-title":"Indian J Urol"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0085","first-page":"23","article-title":"Five-year relative survival from prostate, breast, colorectal and lung cancer","volume":"13","author":"Ellison","year":"2001","journal-title":"Health Rep"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0086","first-page":"545","article-title":"Comparison of prostate cancer patient\u2019s survival in Belarus and Lithuania","volume":"6","author":"Smailyte","year":"2011","journal-title":"Cent Eur J Med"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0087","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdj139","article-title":"Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis","volume":"17","author":"Houterman","year":"2006","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jncc.2026.01.005_bib0088","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.bjc.6601696","article-title":"Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001","volume":"90","author":"Coleman","year":"2004","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.jncc.2026.01.005_bib0089","first-page":"103","article-title":"Net survival of major cancers in Zhongshan City of Guangdong Province from 2003 to 2013","volume":"29","author":"Wei","year":"2020","journal-title":"China Cancer"},{"issue":"10","key":"10.1016\/j.jncc.2026.01.005_bib0090","first-page":"747","article-title":"Net survival of cancers in Zhongshan City, Guangdong Province, 1995\u223c2009","volume":"25","author":"Wei","year":"2016","journal-title":"China Cancer"},{"issue":"29","key":"10.1016\/j.jncc.2026.01.005_bib0091","first-page":"39","article-title":"Cancer survival trends in Kuwait, 2000-2013: a population-based study","volume":"1","author":"Alawadhi","year":"2019","journal-title":"Gulf J Oncolog"},{"key":"10.1016\/j.jncc.2026.01.005_bib0092","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CLEP.S442152","article-title":"Cancer survival trends in Southeastern China, 2011\u20132021: a population-based study","volume":"16","author":"Zhou","year":"2024","journal-title":"Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.jncc.2026.01.005_bib0093","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1470-2045(08)70179-7","article-title":"Cancer survival in five continents: a worldwide population-based study (CONCORD)","volume":"9","author":"Coleman","year":"2008","journal-title":"Lancet Oncol"},{"issue":"10125","key":"10.1016\/j.jncc.2026.01.005_bib0094","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jncc.2026.01.005_bib0095","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/ijc.34224","article-title":"National surveillance of cancer survival in Iran (IRANCANSURV): analysis of data of 15 cancer sites from nine population-based cancer registries","volume":"151","author":"Nemati","year":"2022","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0096","first-page":"203","article-title":"Cancer survival statistics in China 2019\u20132021: a multicenter, population-based study","volume":"4","author":"Zeng","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"8","key":"10.1016\/j.jncc.2026.01.005_bib0097","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1471-2407-8-368","article-title":"Incidence, mortality and survival patterns of prostate cancer among residents in Singapore from 1968 to 2002","volume":"16","author":"Chia","year":"2008","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0098","article-title":"Trends in long-term cancer survival in Cali, Colombia: 1998-2017","volume":"53","author":"Bravo","year":"2022","journal-title":"Colomb Med (Cali)"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0099","doi-asserted-by":"crossref","first-page":"23","DOI":"10.25100\/cm.v49i1.3689","article-title":"Reliable information for cancer control in Cali, Colombia","volume":"49","author":"Bravo","year":"2018","journal-title":"Colomb Med"},{"key":"10.1016\/j.jncc.2026.01.005_bib0100","article-title":"Survival differences between the USA and an urban population from China for all cancer types and 20 individual cancers: a population based study","volume":"37","author":"Fu","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102289","article-title":"Incidence and survival of patients with prostate cancer in North-Rhine Westphalia, Germany","volume":"23","author":"Karpinski","year":"2025","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"10.1016\/j.jncc.2026.01.005_bib0102","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ijc.34416","article-title":"Longterm survival trends in solid cancers in the Nordic countries marking timing of improvements","volume":"152","author":"Hemminki","year":"2023","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.jncc.2026.01.005_bib0103","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1470-2045(07)70245-0","article-title":"Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study","volume":"8","author":"Berrino","year":"2007","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jncc.2026.01.005_bib0104","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1470-2045(07)70246-2","article-title":"Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data","volume":"8","author":"Verdecchia","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jncc.2026.01.005_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102147","article-title":"Progress in cancer survival across last two decades: a nationwide study of over 1.2 million Polish patients diagnosed with the most common cancers","volume":"78","author":"Caetano Dos Santos","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0106","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdn639","article-title":"Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis","volume":"20","author":"Gondos","year":"2009","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.jncc.2026.01.005_bib0107","doi-asserted-by":"crossref","first-page":"18165","DOI":"10.1002\/cam4.6392","article-title":"Time-trends and age and stage differences in 5-year relative survival for common cancer types by sex in the canton of Zurich, Switzerland","volume":"12","author":"Wanner","year":"2023","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0108","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CEJ.0000000000000372","article-title":"Survival of solid cancer patients in France,1989-2013: a population-based study","volume":"26","author":"Cowppli-Bony","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jncc.2026.01.005_bib0109","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/CEJ.0000000000000304","article-title":"Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study","volume":"26","author":"Grosclaude","year":"2017","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0110","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1016\/j.canep.2011.08.001","article-title":"A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study","volume":"36","author":"Holmberg","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jncc.2026.01.005_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102378","article-title":"Regional disparities in cancer survival in Iran: insight from a national surveillance of cancer survival in iran (IRANCANSURV)","volume":"85","author":"Nemati","year":"2023","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"10.1016\/j.jncc.2026.01.005_bib0112","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/annonc\/mdr131","article-title":"Survival from common and rare cancers in Germany in the early 21st century","volume":"23","author":"Hiripi","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0113","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/bju.13537","article-title":"Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?","volume":"119","author":"Winter","year":"2017","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.jncc.2026.01.005_bib0114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijc.22683","article-title":"Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis","volume":"121","author":"Gondos","year":"2007","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.jncc.2026.01.005_bib0115","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/ijc.29316","article-title":"Recent cancer survival in Germany: an analysis of common and less common cancers","volume":"136","author":"Jansen","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jncc.2026.01.005_bib0116","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1097\/CEJ.0000000000000378","article-title":"Survival from cancer in the north region of Portugal: results from the first decade of the millennium","volume":"26","author":"Antunes","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jncc.2026.01.005_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102339","article-title":"Cancer survival in the northwestern of S\u00e3o Paulo State, Brazil: a population-based study","volume":"83","author":"Mafra","year":"2023","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0118","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.canep.2013.08.006","article-title":"Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers","volume":"37","author":"Charvat","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0119","doi-asserted-by":"crossref","first-page":"445","DOI":"10.32394\/rpzh.2020.0143","article-title":"Survival in men diagnosed with prostate cancer in Poland in the years 2000 - 2014 compared to European countries based on Concord-3","volume":"71","author":"Gliniewicz","year":"2020","journal-title":"Rocz Panstw Zakl Hig"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0120","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4143\/crt.2016.613","article-title":"Survival of cancer patients in Northeast China: analysis of sampled cancers from population-based cancer registries","volume":"49","author":"Li","year":"2017","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0121","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2478\/raon-2021-0003","article-title":"Trends in population-based cancer survival in Slovenia","volume":"55","author":"Zadnik","year":"2021","journal-title":"Radiol Oncol"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0122","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0123","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.2005.11.148","article-title":"Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis","volume":"23","author":"Brenner","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0124","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/annonc\/mdr414","article-title":"Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths","volume":"23","author":"Neppl-Huber","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0125","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/ijc.25101","article-title":"Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancers","volume":"127","author":"Colonna","year":"2010","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cncr.20288","article-title":"Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival","volume":"101","author":"Jemal","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0127","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0128","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0129","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jncc.2026.01.005_bib0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/028418699431348","article-title":"Cancer patient survival - patterns, comparisons, trends - a population- based Cancer Registry study in Finland","volume":"38","author":"Teppo","year":"1999","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0131","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1464-410X.2011.10523.x","article-title":"Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study","volume":"109","author":"Deorah","year":"2012","journal-title":"BJU Int"},{"issue":"15","key":"10.1016\/j.jncc.2026.01.005_bib0132","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1002\/cam4.2551","article-title":"Current trend of worsening prognosis of prostate small cell carcinoma: a population-based study","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0133","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ejca.2008.11.029","article-title":"Survival trends in European cancer patients diagnosed from 1988 to 1999","volume":"45","author":"Verdecchia","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jncc.2026.01.005_bib0134","series-title":"World Cancer Report 2008","first-page":"12","article-title":"Chapter 1.1. Introduction: needs and prospects for cancer control","year":"2008"},{"issue":"13","key":"10.1016\/j.jncc.2026.01.005_bib0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends","volume":"94","author":"Etzioni","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0136","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostatespecific antigen screening: importance of methods and context","volume":"101","author":"Draisma","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.jncc.2026.01.005_bib0137","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/jnci\/djp278","article-title":"Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005","volume":"101","author":"Welch","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0138","first-page":"264","article-title":"Screening for prostate cancer","volume":"59","author":"Brawley","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0139","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-148-6-200803180-00209","article-title":"Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer","volume":"148","author":"Wilt","year":"2008","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MLR.0b013e31827da979","article-title":"Limitations of basing screening policies on screening trials: the US preventive services task force and prostate cancer screening","volume":"51","author":"Etzioni","year":"2013","journal-title":"Med Care"},{"issue":"162","key":"10.1016\/j.jncc.2026.01.005_bib0141","first-page":"15","article-title":"Loss-adjusted hospital and population-based survival of cancer patients","author":"Ganesh","year":"2011","journal-title":"IARC Sci Publ"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0142","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cncr.11208","article-title":"Progress in cancer screening practices in the United States: results from the 2000 national health interview survey","volume":"97","author":"Swan","year":"2003","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jncc.2026.01.005_bib0143","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.2018.19941","article-title":"Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015","volume":"321","author":"Mahal","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jncc.2026.01.005_bib0144","unstructured":"Robotic surgery and cancer [Internet]. Cancer today. Summer Accessed July 20, 2025 https:\/\/www.cancertodaymag.org\/summer2020\/robotic-surgery-and-cancer\/."},{"issue":"12","key":"10.1016\/j.jncc.2026.01.005_bib0145","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jncc.2026.01.005_bib0146","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.jncc.2026.01.005_bib0147","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2015.11.068","article-title":"Time trends in histological features of latent prostate cancer in Japan","volume":"195","author":"Kimura","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.jncc.2026.01.005_bib0148","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2021.100653","article-title":"Prostate cancer screening using prostate-specific antigentests in a high-risk population in China: a cost-utility analysis","volume":"95","author":"Qin","year":"2021","journal-title":"Curr Ther Res Clin Exp"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0149","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-004-0842-0","article-title":"Mass screening of prostate cancer in Changchun city of China","volume":"36","author":"Li","year":"2004","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.jncc.2026.01.005_bib0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12032-009-9409-3","article-title":"Clinical and pathological characteristics of screen detected versus clinically diagnosed prostate cancer in Nanjing, China","volume":"28","author":"Hua","year":"2011","journal-title":"Med Oncol"},{"key":"10.1016\/j.jncc.2026.01.005_bib0151","unstructured":"Shanghai Municipal Health Commission. Understanding prostate cancer correctly: early detection and treatment are essential [Internet]. May 10, 2024 https:\/\/wsjkw.sh.gov.cn\/zl\/20240510\/16bf1293c5cd477884c1228c9bf120f8.html."},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0152","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7196\/SAMJ.9192","article-title":"Waiting times for prostate cancer diagnosis in KwaZulu-natal, South Africa","volume":"105","author":"Singh","year":"2015","journal-title":"S Afr Med J"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0153","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.bjc.6605752","article-title":"Socioeconomic inequalities in cancer survival in England after the NHS cancer plan","volume":"103","author":"Rachet","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0154","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.canep.2015.05.006","article-title":"The impact of age at diagnosis on socioeconomic inequalities in adult cancer survival in England","volume":"39","author":"Nur","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"13","key":"10.1016\/j.jncc.2026.01.005_bib0155","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/cncr.24324","article-title":"Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study","volume":"115","author":"Lin","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0156","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrurol.2014.21","article-title":"Small cell carcinoma of the prostate","volume":"11","author":"Nadal","year":"2014","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.jncc.2026.01.005_bib0157","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1507\/endocrj.EJ18-0563","article-title":"Molecular analysis and literature-based hypothesis of an immunonegative prostate small cell carcinoma causing ectopic ACTH syndrome","volume":"66","author":"Takeuchi","year":"2019","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.jncc.2026.01.005_bib0158","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/07853890.2016.1168936","article-title":"Small cell carcinoma of the prostate presenting with cushing syndrome. A narrative review of an uncommon condition","volume":"48","author":"Rueda-Camino","year":"2016","journal-title":"Ann Med"},{"issue":"15","key":"10.1016\/j.jncc.2026.01.005_bib0159","first-page":"1313","article-title":"Determinants of completion of cancer directed treatment: an experience from a rural cancer centre, sangrur, Punjab state, India","volume":"1","author":"Budukh","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jncc.2026.01.005_bib0160","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/GO.20.00122","article-title":"Cancer statistics, 2020: report from national cancer registry programme, India","volume":"6","author":"Mathur","year":"2020","journal-title":"JCO Glob Oncol"}],"container-title":["Journal of the National Cancer Center"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005426000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005426000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:14:20Z","timestamp":1778926460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667005426000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":160,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2667005426000062"],"URL":"https:\/\/doi.org\/10.1016\/j.jncc.2026.01.005","relation":{},"ISSN":["2667-0054"],"issn-type":[{"value":"2667-0054","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A global review and perspective on prostate cancer survival: findings from survival studies of cancer registration data","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Cancer Center","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jncc.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Chinese National Cancer Center. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}